Journal of Shanghai Jiao Tong University (Medical Science) >
Application of extracorporeal membrane oxygenation to adults with cardiogenic shock and cardiac arrest in hospital
Received date: 2023-04-24
Accepted date: 2023-10-31
Online published: 2024-02-01
Supported by
Suzhou Science and Technology Development Plan (Minsheng Technology-Medical and Health Applied Basic Research) Foundation(SYSD2018064)
Objective ·To assess the effect of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) treatment on the mortality rate of patients suffering from cardiogenic shock and cardiac arrest in hospital. Methods ·A total of 19 patients with cardiogenic shock or cardiac arrest who were treated with VA-ECMO treatment in Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine from September 2017 to March 2022 were included in the retrospective study. Patients were divided into extracorporeal cardiopulmonary resuscitation (ECPR) group (n=9) and VA-ECMO for cardiogenic shock (E-CS) group (n=10) according to whether cardiac arrest had occurred. The general demographic data, clinical data, Sequential Organ Failure Assessment (SOFA) scores, postoperative complications and prognostic indicators of the two groups of patients were collected. Univariate and multivariate Cox proportional hazard regression analyses were used to evaluate the correlation between each covariate and hospital mortality. Results ·Among the included patients, there were 15 males (78.9%), with an average age of 46.5 (34.5, 61.6) years. The incidence of postoperative complications was as follows: bleeding (47.4%), AKI (36.8%), infection (31.6%), limb ischemia (15.8%) and cerebrovascular accident (5.3%). The duration of VA-ECMO was 4.0 (2.0, 6.8) days, and the intensive care duration was 11.5 (5.8, 26.2) days; the ECMO withdrawal success rate was 63.2%, and the hospital mortality was 63.2%. The results of univariate Cox proportional hazard regression analysis showed that AKI (prior to VA-ECMO initiation), postoperative complications of infection and limb ischemia were correlated with the hospital mortality of patients (all P<0.05). The results of multivariate Cox proportional hazard regression analysis showed that AKI (prior to VA-ECMO initiation), postoperative complications of infection and limb ischemia were also independent risk factors for the hospital mortality of patients (all P<0.05). Conclusion ·For patients with cardiogenic shock and cardiac arrest treated with VA-ECMO, AKI (prior to VA-ECMO initiation), postoperative infection and limb ischemia are independently associated with higher hospital mortality.
Mingliang SUI , Weibing TANG , Changjiang WU , Chaofa HUANG , Yadi YANG , Damei XIA . Application of extracorporeal membrane oxygenation to adults with cardiogenic shock and cardiac arrest in hospital[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(12) : 1529 -1534 . DOI: 10.3969/j.issn.1674-8115.2023.12.007
1 | RAO P, KHALPEY Z, SMITH R, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest[J]. Circ Heart Fail, 2018, 11(9): e004905. |
2 | 梁立丰, 张文娟. 预测重症患者院内心脏骤停列线图的建立与验证[J]. 中华急诊医学杂志, 2023, 32(1): 38-45. |
2 | LIANG L F, ZHANG W J. Development and validation of a nomogram to predict in-hospital cardiac arrest in critically ill patients[J]. Chinese Journal of Emergency Medicine, 2023, 32(1): 38-45. |
3 | COMBES A, PRICE S, SLUTSKY A S, et al. Temporary circulatory support for cardiogenic shock[J]. Lancet, 2020, 396(10245): 199-212. |
4 | SMITH M, VUKOMANOVIC A, BRODIE D, et al. Duration of venoarterial extracorporeal life support (VA-ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry[J]. Crit Care, 2017, 21(1): 45. |
5 | VAKIL D, SOTO C, D′COSTA Z, et al. Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation[J]. J Cardiothorac Surg, 2021, 16(1): 290. |
6 | KAUSHAL M, SCHWARTZ J, GUPTA N, et al. Patient demographics and extracorporeal membranous oxygenation (ECMO)-related complications associated with survival to discharge or 30-day survival in adult patients receiving venoarterial (VA) and venovenous (VV) ECMO in a quaternary care urban center[J]. J Cardiothorac Vasc Anesth, 2019, 33(4): 910-917. |
7 | COMBES A, LEPRINCE P, LUYT C E, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock[J]. Crit Care Med, 2008, 36(5): 1404-1411. |
8 | 赵帅. VA-ECMO辅助心脏重症患者的临床结局及早期死亡危险因素分析[D]. 北京: 北京协和医学院, 2021. |
8 | ZHAO S. Analysis of clinical outcomes and risk factors for early mortality in patients with sever cardiac disease assisted by VA-ECMO[D]. Beijing: Peking Union Medical College, 2021. |
9 | CELI?SKA-SPODAR M, KU?MIERCZYK M, ZIELI?SKI T, et al. Current applications and outcomes of venoarterial extracorporeal membrane oxygenation based on 6 years of experience: risk factors for in?hospital mortality[J]. Pol Arch Intern Med, 2021, 131(12): 16145. |
10 | 陈晓华, 陈俊宇, 王润东, 等. 行体外心肺复苏的院内心搏骤停患者使用主动脉内球囊反搏与住院死亡关系的研究: 一项基于文献数据的二次分析[J]. 中华危重病急救医学, 2022, 34(3): 269-273. |
10 | CHEN X H, CHEN J Y, WANG R D, et al. Relationship of in-hospital mortality and using intra-aortic balloon pump with extracorporeal cardiopulmonary resuscitation in patients with cardiac arrest: a secondary analysis based on literature data[J]. Chinese Critical Care Medicine, 2022, 34(3): 269-273. |
/
〈 |
|
〉 |